1-8 of 8
Parveen Wasi
Close
Sort by
Journal Articles

A Retrospective Cohort Study of Donor Cell Leukemia

Brittany Salter, Omar Raslan, Suzanne Demczuk, Brian Leber, Alejandro Garcia-Horton, Irwin Walker, Tobias Berg, Darci Butcher, Kylie L. Lepic, Elizabeth McCready, Parveen Wasi, Dina Khalaf
Journal: Blood
Blood (2022) 140 (Supplement 1): 12916–12917.
https://doi.org/10.1182/blood-2022-164643
Published: 2022
Journal Articles

Fitness Assessment of Elderly Patients with AML and Outcomes

Tony HT Chen, Joshua Xu, Hassan Zahreddine, Brian Leber, Irwin Walker, Tobias Berg, Kylie L. Lepic, Parveen Wasi, Tom Kouroukis, Christopher M. Hillis, Justin Y. Lee, Dina Khalaf
Journal: Blood
Blood (2021) 138 (Supplement 1): 3379.
https://doi.org/10.1182/blood-2021-152612
Published: 2021
Journal Articles

Hemoglobinopathy Education in Canadian Hematology Training Programs: How Much Are Residents Learning?

Madeleine M Verhovsek, BSc, MD FRCPC, Vicky R Breakey, BSc, MD MD FRCPC, Richard Ward, MBBS, MSc, MRCP, FRCPath, Shannon M Bates, MD MSc, Parveen Wasi, MD FRCP(C), Nancy Robitaille, MD
Journal: Blood
Blood (2014) 124 (21): 2168.
https://doi.org/10.1182/blood.V124.21.2168.2168
Published: 2014
Journal Articles

Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia

Clinical Trials & Observations
Steven P. Treon, Andrew R. Branagan, Leukothea Ioakimidis, Jacob D. Soumerai, Christopher J. Patterson, Barry Turnbull, Parveen Wasi, Christos Emmanouilides, Stanley R. Frankel, Andrew Lister, Pierre Morel, Jeffrey Matous, Stephanie A. Gregory, Eva Kimby
Journal: Blood
Blood (2009) 113 (16): 3673–3678.
https://doi.org/10.1182/blood-2008-09-177329
Published: 2009
Journal Articles

Long Term Responses to Fludarabine and Rituximab in Waldenstrom’s Macroglobulinemia

Steven Treon, MD, PhD, Andrew Branagan, Leukothea Ioakimidis, PhD, Jacob Soumerai, Christopher Patterson, MD, Parveen Wasi, MD, FRCP(C), Christos Emmanouilides, MD, PhD, Stanley R. Frankel, MD, T. Andrew Lister, MD, Pierre Morel, MD, Jeffrey Matous, MD, Stephanie A. Gregory, MD, Eva K. Kimby, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3057.
https://doi.org/10.1182/blood.V112.11.3057.3057
Published: 2008
Journal Articles

Outcomes of Elderly Patients with AML in the Hamilton Area: How Are We Doing?

Sadiya Kukaswadia, MD, Tina Hsu, MD, Parveen Wasi, MD, FRCP(C)
Journal: Blood
Blood (2008) 112 (11): 4690.
https://doi.org/10.1182/blood.V112.11.4690.4690
Published: 2008
Journal Articles

A Phase I Trial of Two Sequence-Specific Schedules of Decitabine and Vorinostat in Patients with Acute Myeloid Leukemia (AML).

Karen W.L. Yee, MD, Mark D. Minden, MD, Joseph Brandwein, MD, Aaron Schimmer, MD, Andre Schuh, MD, Vikas Gupta, MD, Hans A. Messner, MD, Ronan Foley, MD, Parveen Wasi, MD, James A. Zwiebel, MD, Brian Leber, MD
Journal: Blood
Blood (2007) 110 (11): 908.
https://doi.org/10.1182/blood.V110.11.908.908
Published: 2007
Journal Articles

Combination Therapy with Rituximab and Fludarabine in Waldenstrom’s Macroglobulinemia.

Steven P. Treon, Andrew Branagan, Parveen Wasi, Christos A. Emmanouilides, Stanley R. Frankel, Andrew Lister, Pierre Morel, Jeffrey Matous, Sari Heitner Enschede, Eva Kimby
Journal: Blood
Blood (2004) 104 (11): 753.
https://doi.org/10.1182/blood.V104.11.753.753
Published: 2004